Promoting |
Tumor cells |
Colorectal cancer cells |
Fas, TNF |
Suppressive immune cells |
90 |
|
|
Melanoma cells |
Fas/FasL |
Apoptosis of T cells |
91, 82 |
|
|
Nasopharyngeal carcinoma cells |
Galectin-9/Tim-3 |
Induce apoptosis of T cells |
92 |
|
|
Solid tumor/AML cells |
JAK3, Fas/FasL |
Suppress T cell and NK cells |
93 |
|
|
Breast cancer cells |
NF-kappa B |
Decrease T cell number |
84 |
|
|
Mammary carcinoma cells |
Perforin, cyclin D3, JAK3 |
Suppress NK cell function |
77 |
|
|
Ovarian tumor cells |
FasL |
T cell apoptosis, suppress T cell receptor |
79 |
|
|
Acute myeloid leukemia cells |
TGF-β1 |
Suppress NK cell function |
80 |
|
|
Mesothelioma cells |
NKG2D |
Suppress T cell and NK cell function |
96 |
|
|
Squamous cell carcinoma cells |
Fas/FasL |
Promoting T regulatory cell expansion |
82 |
|
|
Melanoma cells |
|
Promote T regulatory cell expansion |
82 |
|
|
Murine mammary tumor cells |
IL-6 |
DC differentiation |
86 |
|
|
Mammary adenocarcinoma cells |
IL-6, VEGF, PGE2, TGF-β |
Accumulation of myeloid-derived suppressor cells |
88 |
|
|
Colon carcinoma CT26 cells, lymphoma EL4 cells, embryo NIH/3T3 fibroblasts , lung adenocarcinoma H23 cells, mammary adenocarcinoma cells |
Hsp72, TLR2, STAT3 |
Activation and enhancement of MDSCs' suppressive ability |
75 |
|
|
Ovarian cancer cells |
ATF2, MTA1, ROCK1/2 |
Angiogenesis in ovarian serous cancer |
76 |
|
|
Squamous carcinoma A431 cells, MDA-MB-231 breast adenocarcinoma cells, A549 NSCL cells, H1299 NSCL cells |
Hx or Reox |
Regulation of tumor metastasis and angiogenesis |
98 |
|
|
Pancreatic adenocarcinoma cells |
Tetraspanin D6.1A/CO-029 |
Induce systemic angiogenesis |
99 |
Inhibiting |
Tumor cells |
Non-small cell lung cancer cells |
MAGE peptides |
T cell responses and NK cell lytic activity increased |
101 |
|
|
Fibrosarcoma cells |
C1C2-fused antigen |
Induction of a more potent antigen-specific anti-tumor immune response in vivo |
103 |
|
|
Murine lymphoma E.G7-OVA cells |
SEA-TM |
Promote induction of specific anti-tumor immune response |
104 |
|
|
Murine colon carcinoma cells, murine melanoma cells |
HSP70 |
Improve immunostimulatory activities |
106 |
|
|
Human pancreas cells, human colon cells |
HSP70 |
Stimulate migratory and cytolytic activity of NK cells |
108 |
|
APCs |
Autologous monocyte derived DCs |
MAGE3 peptides, HLA-A2, HLA-BC |
T cell responses |
102 |
|
|
Spleen-derived murine D1 DCs |
HSC73, MHCII, Mac-1 integrin, CD9, MFG-E8 |
Elicit potent T cell-dependent immune responses |
110 |
|
|
DCs |
NKG2D, IL-15Ralpha |
Promote NK cell activation and proliferation |
115 |
|
|
DCs |
MHCII |
Elicit T cell-dependent immune responses |
113 |
|
|
NK cells |
FasL, CD56, perforin |
Deliver cytotoxic molecules |
114 |